Cost of treating breast cancer substantial and increasing in New Zealand.
In: PharmacoEconomics & Outcomes News, Jg. 892 (2021-11-27), Heft 1, S. 11-11
serialPeriodical
Zugriff:
During the treatment phase, surgery costs accrued the largest proportion (35%) of total cost, followed by costs for immunotherapy (18%), radiotherapy (17%) and diagnostic tests, scans and biopsies (16%). The mean public health cost of breast cancer was $NZ44 954 per patient for the treatment and follow-up phases combined. [Extracted from the article]
Titel: |
Cost of treating breast cancer substantial and increasing in New Zealand.
|
---|---|
Zeitschrift: | PharmacoEconomics & Outcomes News, Jg. 892 (2021-11-27), Heft 1, S. 11-11 |
Veröffentlichung: | 2021 |
Medientyp: | serialPeriodical |
ISSN: | 1173-5503 (print) |
DOI: | 10.1007/s40274-021-08206-0 |
Schlagwort: |
|
Sonstiges: |
|